Cite
Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes and prognostic value of molecular markers
MLA
Felice Giangaspero, et al. Chemoradiation for Anaplastic Oligodendrogliomas: Clinical Outcomes and Prognostic Value of Molecular Markers. Jan. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ddaf3f5412832e4075005442efe576d8&authtype=sso&custid=ns315887.
APA
Felice Giangaspero, Riccardo Maurizi Enrici, Giuseppe Minniti, Gaetano Lanzetta, Domenica Di Stefano, Mattia Falchetto Osti, Andrea Pace, Claudia Scaringi, Stefania Scarpino, & Antonella Arcella. (2014). Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes and prognostic value of molecular markers.
Chicago
Felice Giangaspero, Riccardo Maurizi Enrici, Giuseppe Minniti, Gaetano Lanzetta, Domenica Di Stefano, Mattia Falchetto Osti, Andrea Pace, Claudia Scaringi, Stefania Scarpino, and Antonella Arcella. 2014. “Chemoradiation for Anaplastic Oligodendrogliomas: Clinical Outcomes and Prognostic Value of Molecular Markers,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ddaf3f5412832e4075005442efe576d8&authtype=sso&custid=ns315887.